Publication | Closed Access

Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial

Metabolic SyndromeMetabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseLiver PhysiologyPharmacologyPathologyPlacebo-controlled TrialHepatotoxicityLiver DiseaseFatty Liver DiseaseMedicineHealth Sciences